Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BMS Deals Diabetes Drugs, Solidifies Specialist Stance

01 Feb 2007

Related Content

Anything but Academic: Lessons From the PPAR Failures

01 Jun 2006

The Double-edged Sword of Diabetes Drug Development

01 Dec 2005

Genmab/GSK: An Impressive Display of Biotech's Increased Leverage

01 Jan 2007

AstraZeneca Joins the In-Licensing Game

01 Feb 2006

Generic Plavix: As Bristol Swoons, Broad Implications

01 Sep 2006

Pharma's High Hopes for Diabetes Drugs Revived

01 Sep 2006

The Outsourcing Dilemma

01 Sep 2006

Pharmaceutical Strategic Alliances 2006: Forcing Externalization at Big Pharma

01 Oct 2006

NicOx's Naproxcinod: Hitting the NSAID Sweet Spot?

01 Feb 2007

Related Companies

AstraZeneca PLC

Bristol Myers Squibb Company

Bayer AG

Roche Holding AG

Pfizer Inc.

AtheroGenics, Inc.

Sanofi

Merck & Co., Inc.

Cleveland Clinic

Nicox S.A.

Novartis AG

Genmab A/S

Vertex Pharmaceuticals Incorporated

Johnson & Johnson

inVentiv Health Inc.

Arrow Therapeutics

Argenta Discovery Ltd.

Palatin Technologies, Inc.

Additional Topics

Strategy Business Strategies BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.